Boiron SA
PAR:BOI

Watchlist Manager
Boiron SA Logo
Boiron SA
PAR:BOI
Watchlist
Price: 26.7 EUR 3.09%
Market Cap: 468.6m EUR
Have any thoughts about
Boiron SA?
Write Note

P/E
Price to Earnings

19.6
Current
17.4
Median
21.8
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
19.6
=
Market Cap
463.6m EUR
/
Net Income
23.7m EUR
All Countries
Close
Market Cap P/E
FR
Boiron SA
PAR:BOI
463.6m EUR 19.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
756.2B USD 90
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 29
US
Johnson & Johnson
NYSE:JNJ
351.2B USD 24
US
Merck & Co Inc
NYSE:MRK
251.2B USD 20.7
CH
Roche Holding AG
SIX:ROG
200.1B CHF 17.4
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 31.6
CH
Novartis AG
SIX:NOVN
171.5B CHF 10.8
US
Pfizer Inc
NYSE:PFE
151.1B USD 35.5
Earnings Growth P/E to Growth
FR
Boiron SA
PAR:BOI
Average P/E: 31
19.6
13%
1.5
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
24
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.5
719%
0

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
12.1
2-Years Forward
P/E
11.4
3-Years Forward
P/E
11.4

See Also

Discover More